EN | RU
EN | RU

Help Support

Back

A review of neuropathic pain: from Guidelines to Clinical practice

A review of neuropathic pain: from Guidelines to Clinical practice A review of neuropathic pain: from Guidelines to Clinical practice
A review of neuropathic pain: from Guidelines to Clinical practice A review of neuropathic pain: from Guidelines to Clinical practice

Neuropathic pain is a chronic condition with an estimated prevalence of 6.9–10.0% in the general population. It imposes a significant burden on society and health care systems. A multitude of factors such as increasing obesity, the ageing population, and improved survival rates of cancer patients are likely to increase the risk of neuropathic pain in future. The treatment of neuropathic soluble orally administered drugs.

See All

What's new?

Neuropathic pain is a chronic condition with an estimated prevalence of 6.9–10.0% in the general population.

Comments (3)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: